Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.67 USD | -1.11% | -14.57% | -43.24% |
05-23 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
05-22 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.24% | 851M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- HC Wainwright Assumes Scholar Rock at Buy with $30 Price Target